Inhibikase Therapeutics, Inc.
$2.38
+0.07 (+3.03%)
Price as of Sep 01, 2026 market close
Performance
- 1 Month
- +7.7%
- 3 Months
- +40.0%
- YTD
- +16.1%
- 1 Year
- +32.2%
Price return, based on split- and dividend-adjusted closing prices.
Risk
- Volatility 1-year annualized
- 63.6%
- Largest decline max drawdown, since Aug 2025
- -26.8%
- Risk-adjusted return Sharpe ratio, 1-year
- 0.75
Own IKT?
See how IKT contributes to your portfolio's return, allocation, and risk.
7-day free trial, then $9/month.